Stock VACC VACY AS
Add to a list
To use this feature you must be a member
Log inSign up

Calendar VACY AS Oslo Bors

Equities

VACC

NO0010714785

End-of-day quote Oslo Bors
Other stock markets
 		5-day change 1st Jan Change
- PTS -.--% Intraday chart for VACY AS -.--% -.--%
05-14 Transcript : Nykode Therapeutics AS, Q1 2024 Earnings Call, May 14, 2024
05-14 Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Chart calendar VACY AS

601d.g8ddFmFls4YGHaHBd-XD3fbygilLxZXnum-q7--qn7Y.yZ4YQCAQ8edVLJe5QJaPuoyY7XYxke-2iDrEi5bl-MXhnTIlFSvg0GdzmQ~3afa7081647ac7ea4cc45d9926363ef7

Upcoming events on VACY AS

20/08/2024 Q2 2024 Earnings Release Pre-market
26/11/2024 Q3 2024 Earnings Release Pre-market
25/02/2025 Q4 2024 Earnings Release Pre-market
19/05/2025 Q1 2025 Earnings Release (Projected)
19/08/2025 Q2 2025 Earnings Release (Projected)
18/11/2025 Q3 2025 Earnings Release (Projected)
03/03/2026 Q4 2025 Earnings Release (Projected)

Past events on VACY AS

Today Annual General Meeting
14/05/2024 06:00 Q1 2024 Earnings Release
28/02/2024 15:00 Q4 2023 Earnings Call
28/02/2024 06:00 Q4 2023 Earnings Release
10/01/2024 23:45 J.P. Morgan Healthcare Conference
15/11/2023 15:00 Q3 2023 Earnings Call
15/11/2023 09:30 Q3 2023 Earnings Release
12/10/2023 15:00 MRNA Cancer Vaccines Summit
11/09/2023 H.C. Wainwright Global Investment Conference
23/08/2023 14:00 Q2 2023 Earnings Call
23/08/2023 05:45 Q2 2023 Earnings Release
07/06/2023 15:00 Jefferies Global Healthcare Conference
30/05/2023 05:00 ABGSC Life Science Summit
12/05/2023 09:01 Q1 2023 Earnings Call
12/05/2023 06:00 Q1 2023 Earnings Release
11/05/2023 09:00 Annual General Meeting
19/04/2023 15:00 VB-C-02 Phase 2 Trail Results Call
28/02/2023 15:00 Q4 2022 Earnings Call
28/02/2023 06:00 Q4 2022 Earnings Release
16/02/2023 13:00 SVB Securities Global Biopharma Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million NOK		Released
Forecast
Spread 		12,4
12,0
3.72%		0,00


314
366
-14.34%		93,3
55,6
67.79%		141
122
15.74%
214

EBITDA
Million NOK		Released
Forecast
Spread 		-98,8
-85,0
-16.18%		0,00


-87,9
10,6
-929.18%		-543
-505
-7.36%		-593
-621
4.51%
-668

EBIT
Million NOK		Released
Forecast
Spread 		-98,9
-85,0
-16.34%		0,00


-94,4
10,6
-990.13%		-549
-564
2.62%		-615
-650
5.32%
-694

Earnings before Tax (EBT)
Million NOK		Released
Forecast
Spread 		-96,0
-83,0
-15.61%		0,00


-97,4
4,79
-2131.68%		-527
-543
3%		-467
-590
20.89%
-723

Net income
Million NOK		Released
Forecast
Spread 		0,00
0,00
- 		1 249


-82,3
4,79
-1817.89%		-442
-447
1.23%		-372
-521
28.59%
-705

EPS
NOK		Released
Forecast
Spread 		-0,35
-0,31
-13.34%		4,25


-0,26
0,01
-5354.6%		-1,55
-1,55
-0.33%		-1,27
-1,74
27.16%
-2,16

Announcement Date15/04/2021/04/2131/03/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million NOK		Released
Forecast
Spread 		33,2
53,3
-37.71%		13,0
105
-87.64%		34,1
10,2
235.85%		33,3
13,0
156.81%		54,2
12,6
328.9%		30,3


24,1
22,9
5.51%		11,0
66,9
-83.57%
68,2


68,2


68,2

EBITDA
Million NOK		Released
Forecast
Spread 		-94,9
-57,0
-66.49%		-197
-6,75
-2827.29%





-121
-164
25.92%		-148
-175
15.13%		-176
-167
-4.85%		-163
-157
-3.52%
-164


-169


-173

EBIT
Million NOK		Released
Forecast
Spread 		-99,4
-57,0
-74.31%		-202
-6,75
-2895.79%		-149
-141
-5.73%


-127
-169
24.74%		-154
-179
13.87%		-182
-173
-5.05%		-169
-164
-3.26%
-171


-175


-180

Earnings before Tax (EBT)
Million NOK		Released
Forecast
Spread 		-106
-57,0
-85.83%		-195
-6,75
-2789.08%		-127
-133
4.62%


-109
-161
32.5%		-134
-187
28.3%		-100
-172
41.85%		-178
-170
-4.76%
-177


-182


-186

Net income
Million NOK		Released
Forecast
Spread 		-84,9
-57,0
-48.84%		-151
-6,75
-2140.86%		-126
-120
-5.11%


-97,9
-145
32.42%		-110
-187
40.83%		-56,5
-164
65.47%		-162
-170
4.82%
-177


-182


-186

EPS
NOK		Released
Forecast
Spread





-0,41
-0,41
0.16%


-0,32
-0,50
36.23%		-0,32
-0,64
49.77%		-0,21
-0,53
59.85%		-0,54
-0,53
-1.88%
-0,54


-0,54


-0,54

Announcement Date23/08/2223/11/2228/02/2312/05/2322/08/2315/11/2328/02/2414/05/24---

Upcoming sector events for VACY AS

17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for VACY AS

Today 14:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
Today BIOCON LIMITED: Q4 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 CELCUITY INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 13:00 IMMUNOME, INC.: Q1 2024 Earnings Release
14/05/2024 12:00 IMMATICS N.V.: Q1 2024 Earnings Release
13/05/2024 PEPTIDREAM INC.: Q1 2024 Earnings Release
14/05/2024 06:00 NYKODE THERAPEUTICS: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. VACC Stock
  4. VACC Stock
  5. Calendar VACY AS